American Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,318
| Closed | -$201K | – | 297 |
|
|
2023
Q2 | $201K | Sell |
2,318
-306
| -12% | -$26.5K | 0.01% | 401 |
|
|
2023
Q1 | $255K | Sell |
2,624
-83
| -3% | -$8.07K | 0.02% | 349 |
|
|
2022
Q4 | $280K | Sell |
2,707
-51
| -2% | -$5.28K | 0.03% | 321 |
|
|
2022
Q3 | $229K | Sell |
2,758
-60
| -2% | -$4.98K | 0.02% | 351 |
|
|
2022
Q2 | $234K | Buy |
2,818
+70
| +3% | +$5.81K | 0.02% | 376 |
|
|
2022
Q1 | $212K | Sell |
2,748
-152
| -5% | -$11.7K | 0.01% | 460 |
|
|
2021
Q4 | $256K | Buy |
+2,900
| New | +$256K | 0.02% | 274 |
|